Annals of Oncology

News:

The International Network for Cancer Treatment and Research (INCTR)
Ann Oncol 11: 637-638.
[PDF] [Request Permissions]

African Organisation for Research and Training in Cancer (AORTIC) to be reactivated
Ann Oncol 11: 638-639.
[PDF] [Request Permissions]

Health spending in UK to rise: How much will there be for cancer?
Ann Oncol 11: 639.
[PDF] [Request Permissions]

Veronesi Minister of Health in Italy
Ann Oncol 11: 639-640.
[PDF] [Request Permissions]

CPT-11 approved, oxaliplatin rejected by FDA
Ann Oncol 11: 640.
[PDF] [Request Permissions]

Fight overTaxol patents erupts
Ann Oncol 11: 641.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 11: 641.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 11: 641-643.
[PDF] [Request Permissions]

Book reviews:

A. Calderoni

Book review
Ann Oncol 11: 644.
[PDF] [Request Permissions]

R. Midgley

Book review
Ann Oncol 11: 764.
[PDF] [Request Permissions]

Editorial:

J.O. Armitage

Management of relapsed Hodgkin's disease patients with high-dose chemotherapy and marrow stem-cell transplantation
Ann Oncol 11: 645-646.
[PDF] [Request Permissions]

Review:

A. Hamilton and M. Piccart

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: A review of the literature on HER-2, p53 and BCL-2
Ann Oncol 11: 647-663.
[Abstract] [PDF] [Request Permissions]

Original articles:

A. Argiris, S. Seropian, and D.L. Cooper

High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease
Ann Oncol 11: 665-672.
[Abstract] [PDF] [Request Permissions]

C.P. Belani, A. Einzig, P. Bonomi, T. Dobbs, M. J. Capozzoli, R. Earhart, L. J. Cohen, and J. D. Luketich

Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer
Ann Oncol 11: 673-678.
[Abstract] [PDF] [Request Permissions]

O. Fitoussi, H. Eghbali, N. Tchen, J. P. Berjon, P. Soubeyran, and B. Hcerni

Semen analysis and cryoconservation before treatment in Hodgkin's disease
Ann Oncol 11: 679-684.
[Abstract] [PDF] [Request Permissions]

C. Haioun, C. Besson, E. Lepage, C. Thieblemont, D. Simon, C. Rose, H. Tilly, A. Sonet, P. Lederlin, M. Attal, J. Brière, F. Reyes, and Groupe d'Etudes des Lymphomes de l'Adulte (GELA)

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients
Ann Oncol 11: 685-690.
[Abstract] [PDF] [Request Permissions]

I. W. Flinn, S. N. Goodman, L. Post, J. Jamison, C. B. Miller, S. Gore, L. Diehl, C. Willis, R. F. Ambinder, and J. C. Byrd

A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL
Ann Oncol 11: 691-695.
[Abstract] [PDF] [Request Permissions]

P. Baas, J. van Meerbeeck, H. Groen, H. Schouwink, S. Burgers, S. Daamen, and G. Giaccone

Caelyx^TM in malignant mesothelioma: A phase II EORTC study
Ann Oncol 11: 697-700.
[Abstract] [PDF] [Request Permissions]

M. Fraile, M. Rull, F. J. Julián, F. Fusté, A. Barnadas, M. Llatjós, E. Castellà, J. R. Gonzalez, V. Vallejos, A. Alastrué, and M. A. Broggi

Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: An approach to its validity
Ann Oncol 11: 701-705.
[Abstract] [PDF] [Request Permissions]

Y. Zhou, S. Wang, A. Gobl, and K. Öberg

The interferon- regulation of interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implications in carcinoid tumors
Ann Oncol 11: 707-714.
[Abstract] [PDF] [Request Permissions]

J. Shamash, S. M. Lee, J. A. Radford, A. Z. S. Rohatiner, J. Chang, G. R. Morgenstern, J. H. Scarffe, D. P. Deakin, and T. A. Lister

Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study
Ann Oncol 11: 715-719.
[Abstract] [PDF] [Request Permissions]

B. Brockstein, D. J. Haraf, K. Stenson, L. Sulzen, M. E. Witt, R. W. Weichselbaum, and E. E. Vokes

A phase I–II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer
Ann Oncol 11: 721-728.
[Abstract] [PDF] [Request Permissions]

P. Schöffski, G. Seeland, H. Engel, V. Grünwald, H. Paul, K. Merkle, R. Kowalski, and A. Ganser

Weekly administration of bendamustine: A phase I study in patients with advanced progressive solid tumours
Ann Oncol 11: 729-734.
[Abstract] [PDF] [Request Permissions]

A. M. Gillespie, T. J. Broadhead, S. Y. Chan, J. Owen, A. P. Farnsworth, M. Sopwith, and R. E. Coleman

Phase I open study of the effects of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer
Ann Oncol 11: 735-741.
[Abstract] [PDF] [Request Permissions]

Clinical cases:

G. Hildebrandt, E. Holler, M. Woenkhaus, G. Quarch, A. Reichle, B. Schalke, and R. Andreesen

Acute deterioration of Charcot-Marie-Tooth disease IA (CMTIA) following 2 mg of vincristine chemotherapy
Ann Oncol 11: 743-747.
[Abstract] [PDF] [Request Permissions]

J. S. de Bono, J. A. Fraser, F. Lee, A. Simpson, C. Lim, S. Naik, M. Soukop, and D. J. Dunlop

Metastatic extragonadal seminoma associated with cardiac transplantation
Ann Oncol 11: 749-752.
[Abstract] [PDF] [Request Permissions]

E. de Bree, M. Christodoulakis, and D. Tsiftsis

Malignant peritoneal mesothelioma treated by continuous hyperthermic peritoneal perfusion chemotherapy
Ann Oncol 11: 753-756.
[Abstract] [PDF] [Request Permissions]

Short reports:

S. Kakolyris, C. Kouroussis, K. Kalbakis, D. Mavroudis, J. Souglakos, N. Vardakis, S. Kremos, and V. Georgoulias

Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin
Ann Oncol 11: 757-760.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

M. Yamagata, Y. Shiratori, Y. Dan, S. Shiina, T. Takayama, M. Makuuchi, and M. Omata

Serum endostatin levels in patients with hepatocellular carcinoma
Ann Oncol 11: 761-762.
[PDF] [Request Permissions]

F. Eckel, C. Lersch, G. Assmann, and E. Schulte-Frohlinde

Phase II trial of low-dose cyclo-phosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer
Ann Oncol 11: 762-763.
[PDF] [Request Permissions]

Corrigendum:

Corrigendum
Ann Oncol 11: 765.
[Abstract] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.